Oulton M, Martin T R, Faulkner G T, Stinson D, Johnson J P
Pediatr Res. 1980 May;14(5):722-8. doi: 10.1203/00006450-198005000-00004.
Several properties of a pellet fraction obtained on centrifuging amniotic fluid at 10,000 X g for 20 min were investigated. From these analyses, we defined a developmental profile which appears to describe the maturational process of the fetal lung surfactant system. At 14 to 18 wk gestation, the pellet fraction consisted of membrane-bound vesicles without internal lamellae. The phospholipid composition did not resemble that of surfactant, the major phospholipid being sphingomyelin. This stage, designated as presurfactant, persisted until 30 to 32 wk gestation. After this time, the phospholipid concentration of the pellet fraction increased continuously throughout development, and gradual but continuous changes in phospholipid composition were observed. Lecithin and phosphatidylinositol increased between 30 and 35 wk gestation. Interruption of pregnancies at this stage, termed onset of surfactant synthesis, resulted in 100% incidence of respiratory distress syndrome. From 36 wk gestation to postterm, the pellet fraction contained structures with the characteristic morphology of the lamellar inclusion bodies. The presence of single membrane components in these preparations did not contribute to the phospholipid composition. Early formed lamellar bodies lacked phosphatidylglycerol and had a high content of phosphatidylinositol. Once phosphatidylglycerol appeared in the lamellar body fraction, it continued to increase, accompanied by a decrease in phosphatidylinositol with little change in lecithin. A phosphatidylglycerol value of greater than 1% of the total phospholipids appeared to represent the stage of maturity at which there was no risk of respiratory distress syndrome.
对羊水在10,000×g离心20分钟后获得的沉淀部分的几种特性进行了研究。通过这些分析,我们定义了一种发育概况,它似乎描述了胎儿肺表面活性剂系统的成熟过程。在妊娠14至18周时,沉淀部分由没有内部板层的膜结合囊泡组成。磷脂组成与表面活性剂不同,主要磷脂是鞘磷脂。这个阶段被称为前表面活性剂阶段,一直持续到妊娠30至32周。此后,沉淀部分的磷脂浓度在整个发育过程中持续增加,并且观察到磷脂组成逐渐但持续的变化。卵磷脂和磷脂酰肌醇在妊娠30至35周之间增加。在此阶段中断妊娠,即表面活性剂合成开始时,呼吸窘迫综合征的发生率为100%。从妊娠36周到期末,沉淀部分包含具有板层包涵体特征形态的结构。这些制剂中单个膜成分的存在对磷脂组成没有贡献。早期形成的板层小体缺乏磷脂酰甘油,磷脂酰肌醇含量高。一旦磷脂酰甘油出现在板层小体部分,它就会持续增加,同时磷脂酰肌醇减少,卵磷脂变化不大。磷脂酰甘油值大于总磷脂的1%似乎代表了没有呼吸窘迫综合征风险的成熟阶段。